PHILADELPHIA--(BUSINESS WIRE)--Applied Biosystems Inc. (NYSE:ABI) today announced during the 58th Annual American Society of Human Genetics (ASHG) Meeting that it has expanded its suite of application-specific bioinformatics solutions to include de novo assembly of small organisms on the SOLiD 3 System, the company’s high-performance next-generation sequencing platform that enables the comprehensive analysis of genomes, transcriptomes and epigenomes. Two analysis tools from SoftGenetics and the European Bioinformatics Institute (EBI) were developed to help researchers reconstruct, assemble, and visualize short read sequencing data generated by Applied Biosystems’ SOLiD™ technology. These tools are currently available through the company’s SOLiD Software Development Community.
